tiprankstipranks
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
US Market
OVID
Ovid Therapeutics
RESEARCH TOOLSreports

Ovid Therapeutics (OVID) Financial Statements

1,730 Followers

Ovid Therapeutics Financial Overview

Ovid Therapeutics's market cap is currently $284.85M. The company's EPS TTM is $0.06; its P/E ratio is -6.90; Ovid Therapeutics is scheduled to report earnings on March 18, 2026, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 7.25M$ 566.00K$ 392.00K$ 1.50M$ 208.38M
Gross Profit$ 6.95M$ 566.00K$ 392.00K$ 1.50M$ 208.38M
Operating Income$ -42.44M$ -61.88M$ -59.28M$ -55.55M$ 124.21M
EBITDA$ -42.14M$ -57.77M$ -57.01M$ -54.17M$ 124.45M
Net Income$ -17.41M$ -26.43M$ -52.34M$ -54.17M$ 122.83M
Balance Sheet
Cash & Short-Term Investments$ 69.64M$ 53.08M$ 105.83M$ 129.00M$ 187.80M
Total Assets$ 150.93M$ 92.17M$ 144.03M$ 155.27M$ 194.54M
Total Debt$ 13.42M$ 14.76M$ 16.00M$ 16.54M$ 0.00
Net Debt$ 266.00K$ -11.55M$ -11.04M$ -28.33M$ -187.80M
Total Liabilities$ 20.27M$ 23.94M$ 56.23M$ 22.99M$ 14.80M
Stockholders' Equity$ 130.66M$ 68.23M$ 87.80M$ 132.27M$ 179.75M
Cash Flow
Free Cash Flow$ -38.33M$ -56.03M$ -45.92M$ -56.65M$ 118.43M
Operating Cash Flow$ -38.33M$ -55.96M$ -45.78M$ -55.23M$ 118.61M
Investing Cash Flow$ -49.85M$ 54.59M$ -2.58M$ -87.88M$ -1.82M
Financing Cash Flow$ 75.21M$ 622.00K$ 30.54M$ 180.66K$ 904.08K
Currency in USD

Ovid Therapeutics Earnings and Revenue History

Income Statement >

Ovid Therapeutics Debt to Assets

Balance Sheet >

Ovid Therapeutics Cash Flow

Cash Flow >

Ovid Therapeutics Forecast EPS vs Actual EPS

Earnings >